MiR-122 in hepatic function and liver diseases
Protein & Cell
;
(12): 364-371, 2012.
Article
in English
| WPRIM
| ID: wpr-757263
ABSTRACT
As the most abundant liver-specific microRNA, microRNA-122 (miR-122) is involved in various physiological processes in hepatic function as well as in liver pathology. There is now compelling evidence that miR-122, as a regulator of gene networks and pathways in hepatocytes, plays a central role in diverse aspects of hepatic function and in the progress of liver diseases. This liver-enriched transcription factors-regulated miRNA promotes differentiation of hepatocytes and regulates lipid metabolism. With regard to liver diseases, miR-122 was shown to stimulate hepatitis C virus (HCV) replication through a unique and unusual interaction with two binding sites in the 5'-UTR of HCV genome to mediate the stability of the viral RNA, whereas inhibit the expression and replication of hepatitis B virus (HBV) by a miR-122-cylin G1/p53-HBV enhancer regulatory pathway. In addition, miR-122 acts as a suppressor of cell proliferation and malignant transformation of hepatocytes with remarkable tumor inhibition activity. Notably, a clinical trial targeting miR-122 with the anti-miR-122 oligonucleotides miravirsen, the first miRNA targeted drug, has been initiated for treatment of HCV infection. With further understanding of the comprehensive roles of miR-122 in hepatic functions and the mechanisms involved in miR-122 down-regulation in chronic hepatitis or hepatocellular carcinoma, miR-122 appears to be a promising candidate for effective therapeutic approaches against tumor and infectious diseases.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
MicroRNAs
/
Lipid Metabolism
/
Genetics
/
Liver
/
Liver Diseases
/
Metabolism
/
Models, Biological
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Protein & Cell
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS